MET and gastric cancer: Cullinane et al.73described that crizotinib inhibition of c‐Met could be tracked in GTL‐16 gastric cancer xenografts and U87MG using 18F‐FLT (fluorothymidine), whereas 18F‐FDG can only be used in GTL‐16.